Triumvira Immunologics

Triumvira Immunologics

  • Founded: 2015
  • Location: Austin, TX
  • Employee range: 11 - 50
  • Clinical stage: Clin1
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: TAC01-HER2
  • Product link:
  • Funding: $45M A Mar 2022; $55M A Aug 2020

job board

Short description:

Adoptive Immunotherapy

Drug notes:

Also additional effort Clin0 solid tumors; TAC-Claudin 18.2 RD/Clin0 multiple cancers; TAC-GPC3 RD hepatocellular carcinoma; TAC-GUCY2C RD multiple cancers; undisclosed RD undisclosed

Long description:

Contact us to add description:


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy